Terbinafine
- TRADE NAME: Lamisil (Novartis)
- INDICATIONS: Fungal infections of the skin and nails
- CLASS: Antifungal / antimycotic, Antimicrobial
- HALF-LIFE: ~36 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amitriptyline, Amphotericin B, Atomoxetine, Caffeine, Carbamazepine, Cimetidine, Codeine, Conivaptan, Cyclosporine, CYP2D6 substrates, Desipramine, Estrogens, Fesoterodine, Fluconazole, Nebivolol, Progestogens, Rifampin, Rifapentine, Saxagliptin, Tamoxifen, Tamsulosin, Tetrabenazine, Thioridazine, Tramadol, Tricyclic antidepressants
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RESPIRATORY.
OTHER.
Page last updated 02/28/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
